IceCure Medical (ICCM)
(Real Time Quote from BATS)
$0.90 USD
0.00 (0.11%)
Updated Aug 7, 2025 12:40 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ICCM 0.90 0.00(0.11%)
Will ICCM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ICCM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ICCM
Viatris (VTRS) Tops Q2 Earnings and Revenue Estimates
Labcorp Holdings (LH) Q2 Earnings and Revenues Top Estimates
ICCM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ascend Wellness Holdings, Inc. (AAWH) Reports Q1 Loss, Misses Revenue Estimates
Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates
IceCure Medical Stock Dips Despite Positive ICESECRET Study Results
Other News for ICCM
IceCure to Report First Half 2025 Financial and Operating Results on August 13, 2025 | ICCM ...
IceCure Announces Expiration and Results of Approximately Two Times Over-Subscribed Rights ...
IceCure Medical (ICCM) Showcases Promising Breast Cancer Data at Tokyo Conference | ICCM Stock News
IceCure Medical announces data presented at Japanese Breast Cancer Society event